ArticleEXCLI journal2015
An updated review of Cucurbitacins and their biological and pharmacological activities.
Article in EXCLI journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Two traditional Apulian varieties ofFrontiers in nutrition · 2025Article
- Exploring effector protein dynamics and natural fungicidal potential in rice blast pathogen Magnaporthe oryzae.PloS one · 2025Article
- Article
- Origin, Evolution, Breeding, and Omics of Chayote, an Important Cucurbitaceae Vegetable Crop.Frontiers in plant science · 2021Review
- The Mechanisms of Cucurbitacin E as a Neuroprotective and Memory-Enhancing Agent in a Cerebral Hypoperfusion Rat Model: Attenuation of Oxidative Stress, Inflammation, and Excitotoxicity.Frontiers in pharmacology · 2021Article
- Metabolomic analysis of the occurrence of bitter fruits on grafted oriental melon plants.PloS one · 2019Article
- Isolation of anticancer constituents from Cucumis prophetarum var. prophetarum through bioassay-guided fractionation.BMC complementary and alternative medicine · 2018Article
- Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549.Investigational new drugs · 2016Article
- Effect of a multimodality Ayurveda treatment in a case of Visphota kushta.Journal of Ayurveda and integrative medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.